Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials. Kappos L, Yiu S, Dahlke F, Coetzee T, et al. Neurology 2025;104:e213558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kappos L, Yiu S, Dahlke F, Coetzee T, et al. Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials. Neurology 2025;104:e213558.
PMID: 40258203